Preclinical and Clinical Studies with Selective Reversible Direct P2Y12Antagonists
Year: 2005
Type: article
Authors: J. J.J van Giezen, Robert G Humphries
Institution: AstraZeneca (Sweden)
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2060258953
